TYRA Offering: a positive outcome, +13.8%

On September 14, 2026, Tyra Biosciences, Inc. reached its Offering. The result was a positive outcome, and the stock moved +13.8% in the window around the event. It had already run -12.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.